APA (7th ed.) Citation

Rorick-Kehn, L. M., Johnson, B. G., Knitowski, K. M., Salhoff, C. R., Witkin, J. M., Perry, K. W., . . . Schoepp, D. D. (2007). In vivo pharmacological characterization of the structurally novel, potent, selective mGlu2/3 receptor agonist LY404039 in animal models of psychiatric disorders. Psychopharmacology, 193(1), 121. https://doi.org/10.1007/s00213-007-0758-3

Chicago Style (17th ed.) Citation

Rorick-Kehn, Linda M., et al. "In Vivo Pharmacological Characterization of the Structurally Novel, Potent, Selective MGlu2/3 Receptor Agonist LY404039 in Animal Models of Psychiatric Disorders." Psychopharmacology 193, no. 1 (2007): 121. https://doi.org/10.1007/s00213-007-0758-3.

MLA (9th ed.) Citation

Rorick-Kehn, Linda M., et al. "In Vivo Pharmacological Characterization of the Structurally Novel, Potent, Selective MGlu2/3 Receptor Agonist LY404039 in Animal Models of Psychiatric Disorders." Psychopharmacology, vol. 193, no. 1, 2007, p. 121, https://doi.org/10.1007/s00213-007-0758-3.